When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. AstraZeneca - Wikipedia

   en.wikipedia.org/wiki/AstraZeneca

   AstraZeneca plc (/ ˌ æ s t r ə ˈ z ɛ n ə k ə /) (AZ) is a British-Swedish [2] [3] [4] multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, United Kingdom. [5]

3. AstraZeneca Plc (AZN) Q3 2024 Earnings Call Transcript - AOL

   www.aol.com/astrazeneca-plc-azn-q3-2024...

   AstraZeneca Plc (NASDAQ: AZN) Q3 2024 Earnings Call Nov 12, 2024, 9:00 a.m. ET. ... all of the materials presented today are available on our AstraZeneca Investor Relations website. Next slide ...

4. AstraZeneca Plc (AZN) Q2 2024 Earnings Call Transcript - AOL

   www.aol.com/astrazeneca-plc-azn-q2-2024...

   Image source: The Motley Fool. AstraZeneca Plc (NASDAQ: AZN) Q2 2024 Earnings Call Jul 25, 2024, 6:45 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants

5. AstraZeneca In Trouble For Employee Detentions in China Over ...

   www.aol.com/astrazeneca-trouble-employee...

   Chinese authorities have detained five current and former employees of AstraZeneca Plc (NASDAQ:AZN) as part of a broader investigation into alleged illegal activities in the pharmaceutical sector.

6. AZN Class Action Notice: Robbins LLP Reminds Stockholders of ...

   lite.aol.com/tech/story/0022/20250113/9331406.htm

   SAN DIEGO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired AstraZeneca PLC (NASDAQ: AZN) securities between February 23, 2022 and December 17, 2024. AstraZeneca describes itself as "a global, science-led biopharmaceutical ...

7. MedImmune - Wikipedia

   en.wikipedia.org/wiki/MedImmune

   On April 23, 2007, it was announced MedImmune and AstraZeneca entered into a definitive agreement under which AstraZeneca intended to acquire MedImmune in an all-cash transaction at US$ 58 per share, or about US$ 15.2 billion. [6] On 19 June 2007 AstraZeneca completed the acquisition paying US$ 15.

8. Zeneca - Wikipedia

   en.wikipedia.org/wiki/Zeneca

   Zeneca (officially Zeneca Group PLC) was a British multinational pharmaceutical company headquartered in London, United Kingdom. It was formed in June 1993 by the demerger of the pharmaceuticals and agrochemicals businesses of Imperial Chemical Industries into a separate company listed on the London Stock Exchange .

9. AstraZeneca-Merck Lynparza Prostate Cancer Treatment ... - AOL

   www.aol.com/news/astrazeneca-merck-lynparza...

   AstraZeneca Plc’s (AZN) and Merck Co.’s (MRK) Lynparza drug has received a green light from the U.S. Food and Drug Administration (FDA) for the treatment of patients with advanced prostate ...